PEOPLE - Johnson & Johnson (US) makes appointment:
This article was originally published in Clinica
Johnson & Johnson (New Brunswick, New Jersey) has appointed David Satcher to the board. Dr Satcher, who formerly served as the 16th surgeon general of the US, currently serves as senior visiting fellow at the Kaiser Family Foundation, Washington, DC.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.